Marek Wojtukiewicz

Marek Wojtukiewicz is a Professor in the Department of Oncology at the Medical University of Bialystok, affiliated with the Faculty of Medicine, which includes divisions of Dentistry and Medical Education. His research focuses on oncology, thrombosis, and clinical therapeutics, with a strong emphasis on cancer biology, metastasis mechanisms, and translational drug development.

Research interests include the interplay between thrombosis and cancer progression, immunotherapy applications in lung and breast cancer, and optimizing clinical care through evidence-based guidelines. He has contributed to studies on biomarkers for treatment efficacy (e.g., Pembrolizumab in NSCLC) and novel agents like giredestrant for hormone-sensitive breast cancer.

Recent publications highlight work on radiotherapy’s dual role in cancer pain management, the role of TFPI-2 in metastasis, and perioperative thrombosis/bleeding risk assessment. He co-authored Polish clinical guidelines on venous thromboembolism and textbook chapters on pancreatic oncology.

• Key Areas: Oncological therapeutics, cancer immunology, thrombosis in malignancies, clinical trials
• Collaborations: International multi-center trials (e.g., bladder cancer immunotherapy, breast cancer phase II studies)

His work bridges basic science and clinical practice, addressing real-world challenges in oncology care and transfusion medicine in oncohematology settings.